ICECaP Adjuvant Working Group
Richard De Abreu Lourenco
STOPCaP: Prognostic Models and Surrogacy
Paul Villanti, Executive Director Programs, Movember
Chris Sweeney, ICECaP Principal Investigator, Medical Oncology, Dana-Farber Cancer Institute
ICECaP Principal Investigator, Medical Oncology, Dana-Farber Cancer Institute.
Medical Oncology, Dana-Farber Cancer Institute.
Biostatistics, Dana-Farber Cancer Institute.
Health Ecocomics, University of Technology Sydney
Medical Oncology, University of Melbourne
Evidence SynthesisUniversity College London
Biostatistics and Bioinformatics, Duke University
Medical OncologyDana-Farber Cancer Institute
Gerhardt Attard Medical Oncology, Uni College London
Progress: prelim data, sample collection, and plans:
Copyright © 2021 Movember. All rights reserved. Movember Foundation is a registered 501(c)3 non-profit organization.